ETX-636

· Ensem Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ETX-636, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]